期刊文献+

盐酸文拉法辛缓释剂与阿米替林治疗广泛性焦虑症的对比观察 被引量:6

Comparative Study of Venlafaxine XR and Amitriptyline in the Rapy of General Anxiety Disorder(GAD)
下载PDF
导出
摘要 目的比较盐酸文拉法辛缓释剂与阿米替林治疗广泛性焦虑症(GAD)的疗效与安全性。方法采用随机分组的方法将56例GAD患者分为盐酸文拉法辛组(28例)和阿米替林组(28例),治疗4周,在治疗前和治疗后1、2、4周分别进行汉密尔顿焦虑量表(HAMA)和副反应量表(TESS)评定疗效和不良反应。结果盐酸文拉法辛与阿米替林对GAD均有显著疗效,两组间无显著性差异。盐酸文拉法辛组不良反应明显小于阿米替林组。结论盐酸文拉法辛缓释剂治疗GAD安全有效,不良反应少。 Objective To compare the efficacy and safety of venlafaxine and amitriptyline in the treatment of GAD.Methods A total of 56 patients with GAD were randomly divided into venlafaxine group(n=28)and amitriptyline group(n=28).They were treated for 4 weeks.The clinical efficacy and side effects were evaluated with HAMA and TESS before treatment and 1,2,4 weeks after treatment.Results There were significant efficacy in both venlafaxine group and amitriptyline group.The side effects in venlafaxine group were significant lower than those in amitriptyline group.Conclusion Venlafaxine shows efficacy and safety in the treatment of GAD with lower side effects.
作者 常双海
出处 《中国健康心理学杂志》 2012年第10期1472-1473,共2页 China Journal of Health Psychology
关键词 精神病学 盐酸文拉法辛缓释剂 阿米替林 广泛性焦虑症 Psychiatry Venlafaxine XR Amitriptyline GAD
  • 相关文献

参考文献3

  • 1中华医学会精神科学会.中国精神疾病分类及诊断标准[M].3版.济南:山东科学技术出版社,2001:75-78.
  • 2江开达.精神病理学[M].北京:人民卫生出版社,2007:410-411.
  • 3Kennedy S H,Andersen H 13. Efficacy of escitalopram in the treat- ment of major depressive disorder compared with conventional selec- tive serotonin reuptake inhibitors and venlafaxine XR : A recta--anal- ysis[J]. Psychiatry Neurosei, 2006,31 ,. 122-131.

共引文献4

同被引文献32

  • 1吴强,李艳红,李凤丽.文拉法新与阿普唑仑治疗广泛性焦虑症的对照研究[J].中国健康心理学杂志,2008,16(5):555-556. 被引量:8
  • 2卢舜飞,朱满连.米氮平与盐酸文拉法辛治疗老年抑郁症患者的对照研究[J].中国预防医学杂志,2009,10(1):59-61. 被引量:3
  • 3唐英.2种文拉法辛制剂治疗抑郁症的对照研究[J].中国新药与临床杂志,2007,26(7):541-543. 被引量:1
  • 4刘炳文,于发平,王连珍.文拉法辛国内临床研究概况[J].中国新药与临床杂志,2007,26(8):616-619. 被引量:16
  • 5Devanand D P. Comorbid psychiatric disorders for depression[J]. Biol Psychiatry, 2002,52 (3) : 236-242.
  • 6Herzallah MM, Moustafa AA, Natsheh JY,et al, Learning from negative feedback inpatients with major depressive disorder is attenuated by SS- RI antidepressants[J].ront Integr Neurosci,2013,23(7):67.
  • 7Nguyen CT, Rosen JA,Bota RG. Aripiprazole partial agonism at 5-HT2C: a comparison of weight gain associated with aripiprazole adjunctive to antidepressants with high versus low serotonergie activitie[J].Prim Care Companion CNS Disord,2012;14(5).pii:PCC.120101386.doi:10.4088/PCC. 120101386.
  • 8Qu SS, Huang Y, Zhang ZJ,et al. A 6-week randomized controlled trial with 4-week follow-up of acupuncture combined withparoxetine in pa- tients with major depressive disorder [J].J Psychiatr Res,2013,47 (6): 726-732.
  • 9Adell A. Lu-AA21004, amultimodal serotoner gicagent, for the potential treatment of depression and anxiety [J].Drugs,2010,12(12) :900-910.
  • 10Herzallah MM,Moustafa AA, Natsheh JY,et al.Depression impairs learn- ing, whereas the selective semtonin reuptake inhibitor, paroxetine, ira- pairs generalization in patients with major depressive disorde[J].J Affect Disord, 2013,151(2):484-492.

引证文献6

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部